98%
921
2 minutes
20
Background/aim: Kimura's disease is a rare chronic inflammatory disorder that commonly affects the head and neck regions, occurring predominantly in Asian men. Elevated eosinophil count and IgE levels in the peripheral blood examination are suggestive of this disease. In this study we report two cases of Kimura's disease, treated with wide excision.
Case Report: The first case was a 58-year-old man presented with asymptomatic left neck mass. The second case was a 69-year-old man with swelling of the right upper arm, which was suggestive of soft tissue mass. Needle biopsy results were suggestive of Kimura's disease in both cases. Elevated WBCs at 8,380/μl (neutrophils: 45%, eosinophils: 33%) for the first case and 5,370/μl (neutrophils: 61.8%, eosinophils: 3.5%) for the second one, and serum IgE at 14.988 IU/ml for the first case and 1,315 IU/ml for the second one were observ. For definitive treatment and diagnosis, wide excisions were performed. Final histopathological results revealed Kimura's disease. Surgical margins were negative even though an ill-demarcated lesion for the first case and high infiltration to the muscle for second case were confirmed.
Conclusion: Wide excision was performed in both cases of Kimura's disease and no recurrence was observed until the final follow-up. Wide excision with negative surgical margin should be recommended for the treatment of Kimura's disease.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188026 | PMC |
http://dx.doi.org/10.21873/invivo.13219 | DOI Listing |
Exp Aging Res
September 2025
Department of Rehabilitation, Naragakuen University, Nara, Japan.
Purpose: Patients with Alzheimer's disease (AD) lose the ability to manage their medications as the disease progresses. Several methods have been used to administer medication to patients at home using Internet of Things (IoT) devices for rehabilitation, but no studies have yet been published investigating the factors that influence the success or failure of this approach in older adults and patients with AD. Therefore, this study aimed to investigate differences in medication-related behaviors and their influencing factors in older adults, both with and without AD, using IoT.
View Article and Find Full Text PDFJACC Case Rep
September 2025
Division of Cardiothoracic Surgery, Department of Surgery, University of California San Francisco, San Francisco, California, USA; Department of Cardiac Surgery, Kaiser San Francisco Medical Center, San Francisco, California, USA. Electronic address:
Background: Kimura disease is a rare inflammatory condition that typically manifests with subcutaneous nodules of the head and neck. This is the first documented case of intracardiac Kimura disease.
Case Summary: A 57-year-old woman presented with a heart murmur and dyspnea.
Background: Atrial fibrillation (AF) is managed with various strategies, including rate and rhythm control, to improve patients' health status. Although its incidence increases with age, how age affects health status improvements following AF treatment remains unknown.
Methods: Using data from a multicenter registry for outpatients with newly recognized AF, baseline and 1-year health status was assessed with the Atrial Fibrillation Effect on Quality-of-life quesTionnaire (AFEQT).
Eur J Nucl Med Mol Imaging
September 2025
Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Chiba-shi, Chiba, 263-8555, Japan.
Purpose: Astrocyte reactivation can be assessed using positron emission tomography (PET) ligands targeting monoamine oxidase B (MAO-B). C-SL25.1188 binds reversibly to MAO-B, allowing precise density measurements, but requires invasive arterial sampling.
View Article and Find Full Text PDFInt J Clin Oncol
September 2025
Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan.
Background: Despite durable benefits of ipilimumab and nivolumab in metastatic renal cell carcinoma (mRCC), early progressive disease (PD), defined as disease progression within 3 months, occurs, and its predictors remain unclear. We aimed to investigate the clinical factors associated with early PD in patients with mRCC treated with this regimen.
Methods: A retrospective analysis of a multi-institutional database identified 193 patients with mRCC treated with ipilimumab plus nivolumab.